Eric Warren Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Eric Warren is Chief Commercial Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 370,326 shares of ESPR, which is worth approximately $618,444. The most recent transaction as insider was on Aug 17, 2022, when has been sold 199 shares (Common Stock) at a price of $6.82 per share, resulting in proceeds of $1,357. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 370K
131.28% 3M change
120.02% 12M change
Total Value Held $618,444

Eric Warren Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2022
SELL
Open market or private sale
$1,357 $6.82 p/Share
199 Reduced 0.37%
53,024 Common Stock
Jul 19 2022
SELL
Open market or private sale
$2,836 $6.58 p/Share
431 Reduced 0.8%
53,223 Common Stock
Jun 17 2022
SELL
Open market or private sale
$1,254 $4.9 p/Share
256 Reduced 0.47%
53,654 Common Stock
May 17 2022
SELL
Open market or private sale
$1,172 $5.98 p/Share
196 Reduced 0.36%
53,910 Common Stock
Mar 14 2022
BUY
Grant, award, or other acquisition
-
13,000 Added 19.37%
54,106 Common Stock
EW

Eric Warren

Chief Commercial Officer
Ann Arbor, MI

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR